ProPhase Labs Inc (NASDAQ: PRPH) suffers from exceptional negative changes in investment behavior: the stock’s recent price decline challenged its longer term uptrend, and negative upside/downside volume developed.
Recent important negative changes in fundamentals have impacted ProPhase Labs Inc (NASDAQ: PRPH): significant quarterly sales deceleration occurred, and significant quarterly earnings deceleration occurred.
In light of these highly negative signals we are reviewing our current Overall Rating of F. We would continue to view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, PRPH is expected to be a modest Value Eraser.
ProPhase Labs has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. ProPhase Labs has a neutral Power Rating of 41 but a poor Appreciation Score of 17, with the Lowest Value Trend Rating the result.
Recent Price Action
ProPhase Labs Inc (NASDAQ: PRPH) stock closed at $4.90 on 4/22/24 after a large decline of -6.8%. Trading volume in this decline was normal. The stock has declined -24.8% during the last week and has performed in line with the market over the last nine months.
Be the first to comment